FDA adds warning to RSV shots from GSK, Pfizer

The regulator is requiring labeling that warns of Guillan-Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.

Delilah Alvarado Member since October 31, 2023

Loading + Follow Following